Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers
Alqurashi, N., Gopalan, V., Smith, Robert A., & Lam, A. K. (2013) Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers. Human pathology, 44(10), pp. 2089-96.
Administrators only | Request a copy from author
This study investigated the clinicopathologic roles of mammalian target of rapamycin (mTOR) expression and its relationship to carcinogenesis and tumor progression in a colorectal adenoma-adenocarcinoma model. Two colon cancer cell lines with different pathologic stages (SW480 and SW48) and 1 normal colonic epithelial cell line (FHC) were used, in addition to 119 colorectal adenocarcinomas and 32 adenomas. mTOR expression profiles at messenger RNA (mRNA) and protein levels were investigated in the cells and tissues using real-time quantification polymerase chain reaction and immunohistochemistry. The findings were correlated with the clinicopathologic features of the tumors. The colon cell line from stage III cancer (SW48) showed higher expression of mTOR mRNA than that from stage II cancer (SW480). At the tissue level, mTOR showed higher mRNA and protein expression in colorectal carcinoma than in adenoma. The mRNA and protein expression was correlated with each other in approximately one-third of the carcinomas and adenomas. High levels of mTOR mRNA expression were noted more in carcinoma or adenoma arising from the distal portion of the large intestine (P = .025 and .019, respectively). Within the colorectal cancer population, a high level of expression of mTOR mRNA was related to the presence of lymph node metastases (P = .031), advanced pathologic stage (P = .05), and presence of persistent disease or tumor recurrence (P = .035). To conclude, the study has indicated that mTOR is likely to be involved in the development and progression of colorectal cancer and is linked to cancer initiation, invasiveness, and progression.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Adenocarcinoma/genetics/metabolism/ secondary, Adenoma/genetics/metabolism/ pathology, Adult, Aged, Aged, 80 and over, Cell Line, Tumor, Colorectal Neoplasms/genetics/metabolism/ pathology, Female, Gene Expression Regulation, Neoplastic, Humans, Intestinal Mucosa/metabolism/pathology, Lymph Nodes/pathology, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Proteins/metabolism, Neoplasm Staging, RNA, Messenger/metabolism, TOR Serine-Threonine Kinases/ genetics/metabolism, Tumor Markers, Biological/metabolism, mTOR, Colorectal, Carcinoma, Expression|
|ISSN:||1532-8392 (online) 0046-8177 (print)|
|Subjects:||Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200) > Cancer Genetics (111203)|
|Divisions:||Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Copyright Owner:||Copyright 2013 Elsevier Inc. All rights reserved.|
|Deposited On:||30 Jul 2014 04:17|
|Last Modified:||30 Jul 2014 22:54|
Repository Staff Only: item control page